Phreesia (PHR)
(Delayed Data from NYSE)
$23.76 USD
+0.44 (1.89%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $23.77 +0.01 (0.04%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum A VGM
Brokerage Reports
Phreesia, Inc. [PHR]
Reports for Purchase
Showing records 41 - 60 ( 170 total )
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Earnings Preview - Updated Thoughts on PHR VEEV Ahead of Earnings Next Week
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Healthcare IT: Proprietary Healthcare Credit Card Transaction Data
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Client Wins Show No Sign of Slowing; Reiterate Overweight Rating on Multi- Pronged Growth Story
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
F4Q Beat; FY Revenue Guide a Touch Light (Likely to Set Up for Beats), but Profitability Better than Consensus; Balaji Appointed as New CFO
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Healthcare IT: Proprietary Healthcare Credit Card Transaction Data
Provider: KeyBanc Capital Markets
Analyst: Research Department